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1.008
ertussis in Brazil: An overview from 1988 to 2009
. Leite ∗, L.C.V. Melo, T.M.I. Vaz, K. Irino
Instituto Adolfo Lutz, São Paulo, Sao Paulo, Brazil
Background: The introduction of pertussis vaccination in
he past decades reduced substantially the number of cases;
owever, despite the high vaccination coverage rates, per-
ussis is still a major threat to public health all over the
orld including Brazil. In this study we present an overview
f pertussis in Brazil in the last two decades.
Methods: Between 1988 and 2009, the National Refer-
nce Laboratory for Pertussis, Instituto Adolfo Lutz, São
aulo, Brazil, received a total of 985 presumptively iden-
iﬁed Bordetella spp strains, isolated from sporadic cases
nd/or some pertussis outbreaks. The strains were for-
arded by the Regional Laboratories in São Paulo State and
y the Central Public Health Laboratories throughout the
ountry. Identiﬁcation of the species was done by standard
ethods. Detection of O1 antigen, and the serotyping were
one by slide agglutination test using O1, and Fim 2 and Fim
antibodies, respectively. Molecular characterization was
one by Pulsed Field Gel Electrophoresis (PFGE).
Results: All the 985 strains were conﬁrmed as Bordetella
ertussis and the most of them belonged to the serotype
,3. Strains from southeastern states accounted for 67%
660/985), most of them from São Paulo State (646/985;
5.6%). The remaining 325 strains were from south region
147/985, 15%), northeastern states (87/985, 8.8%), north
egion (48/985, 5%) and central area (43/985, 4.4%). The
reat majority (81.1%, 799/985) was from children under
welve years of age, and among them 84.4% (675/799)
as from infants aged less than six months. Strains from
dolescents and adults accounted for 3.2% (32/985) and
% (78/985), respectively. The age group was unknown in
pproximately 7.7%. Strains belonging to several PFGE pat-
erns were identiﬁed and some were prevalent.
Conclusion: Different B. pertussis clones circulate all
ver the country. These data do not cover all the country,
nd may represent only a fraction of the actual number of
ertussis cases due to the underreporting, despite pertus-
is is, in Brazil, a reportable disease since 2001. Data on age
istribution of pertussis cases may contribute to develop the
olicy of booster doses of vaccine in adolescents and adults.
oi:10.1016/j.ijid.2010.02.1940
1.009
erogroup B epidemiology in the southern cone of South
merica. A literature review
. Da Silva ∗, M.H. KyawNovartis Vaccines and Diagnostics, Cambridge, MA, USA
Background: The epidemiology of meningococcal disease
iffers greatly by country and time period. Only passive
b
W
d
fternational Congress on Infectious Diseases (ICID) Abstracts
urveillance systems for meningococcal disease exist in
ountries in South America. Thus, little is known about
he pattern of serogroup distribution by country in this
egion. Existing data showed that serogroup B is prevalent
orldwide, with various strains and clones causing endemic,
poradic and epidemic disease. Several of these clones are
ery virulent. Understanding the local and national seroepi-
emiology of group B meningococcal disease is critical for
accine formulations and vaccine policies.
Methods: We examined the current disease burden
aused by serogroup B in the southern cone of South Amer-
ca, comprised of Brazil, Uruguay, Paraguay, Chile, and
rgentina. Clinical data were retrieved following systematic
eview of the literature by country. The 2008 SIREVA report
n invasive disease was also consulted.
Results: Until the late twentieth century, countries in
he southern cone had similar disease epidemiology to Latin
merica as a whole. However, in recent years, this has
hanged. In Brazil, signiﬁcant differences in epidemiology
an be identiﬁed between areas close to other southern cone
ountries and areas bordering Andean or Caribbean coun-
ries. Fluctuations in the proportion of serogroup B versus
erogroup C disease have been observed in southern cone
ountries, yet serogroup B consistently accounted for a sig-
iﬁcant disease burden throughout the early 21st century.
or example, 100% of serotypable meningococcal disease
eported in Chile between 1990 and 2003 was attributed
o serogroup B, as was 40% to 65% of disease in Brazil. In
rgentina, serogroup B consistently accounts for about 60%
f invasive meningococcal disease. Even with the emergence
f disease caused by Serogroups Y and W-135 in Brazil and
rgentina since 2000, serogroup B has remained the cause
f a consistent and ongoing public health problem.
Conclusion: Invasive disease caused by meningococcal
erogroup B remains an important public health issue in the
outhern cone countries. An effective vaccine against group
meningococcal is needed to reduce the burden of disease
n South America.
oi:10.1016/j.ijid.2010.02.1941
1.010
tatus of bloodborne pathogen education for injection
rug users in Indiana hospital emergency departments
. Wenger
Indiana State Department of Health, Indianapolis, IN, USA
Background: The problem of the study was to determine
he status of bloodborne pathogen education for injec-
ion drug users in Indiana hospital emergency departments.
orty-six instruments were returned for a response rate of
3.8%.
Methods: The study was designed to answer the follow-
ng research questions: (a) Do Indiana hospital emergency
epartments have written policies on bloodborne pathogen
ducation for injection drug users? (b) To what extent
o Indiana hospital emergency departments provide blood-
orne pathogen education for injection drug users? and (c)
hat are the major barriers for Indiana hospital emergency
epartments in providing bloodborne pathogen education
or injection drug users? A valid instrument was developed
